Cancer

Just one in five women with breast or cervical cancer in low- and middle-income countries are diagnosed early, compared with more than one in three in wealthier nations. The analysis of data from more than 275,000 women across 39 countries shows stark inequalities in cancer detection and treatment between high-income countries (HICs) and low- and [...]

Women who breastfeed develop protective immune cells that help guard against breast cancer, with effects lasting for more than 30 years, new research shows. The study found that specialised T-cells — immune cells that fight disease — remain in breast tissue long after pregnancy and provide lasting protection, particularly against triple-negative breast cancer, one of [...]

Co-written By Dr Claire Gillvray and Tarang Majmudar, Welbeck Cambridge (2026) Gynaecological cancers, cervical, ovarian, uterine, vaginal, and vulvar, pose a significant health risk across all age groups. While treatment has advanced in recent years, early detection remains the single most crucial factor in improving survival, reducing the need for invasive treatments, and preserving quality [...]

Whole genome sequencing could identify unique genetic features to guide treatment for more than 15,000 breast cancer patients each year in the UK, new research suggests. The technique, which analyses DNA from both patient and tumour to identify genetic changes, helps reveal what drives each cancer and highlights potential treatment targets or resistance. Scientists at [...]

A targeted therapy has improved survival compared with chemotherapy in patients with triple-negative breast cancer who cannot receive immunotherapy. The drug, an antibody-drug conjugate (a treatment that delivers chemotherapy directly to cancer cells), slowed tumour progression and extended survival compared with standard chemotherapy in triple-negative breast cancer – an aggressive form lacking three common receptors [...]

High-risk women can now delay ovary removal surgery through NHS screening, helping them preserve fertility and avoid early surgical menopause. The ROCA test tracks women with BRCA gene mutations every four months, monitoring cancer risk markers instead of requiring immediate preventive surgery. University College London Hospitals NHS Foundation Trust has begun rolling out the programme, [...]

A large, long-term study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine. HPV is the most common sexually transmitted infection worldwide and is the primary cause of cervical [...]

AbbVie said on Monday that it will launch ovarian cancer drug Elahere in the UK at the same list price as in the US. The announcement follows President Donald Trump’s push for drugmakers to align domestic prices with the lowest levels paid by comparable high-income countries under his “most-favoured-nation” policy. The US currently pays nearly [...]

GENinCode shares rose 6 per cent on Thursday after University College London Hospitals (UCLH) became the first NHS trust to introduce its ovarian cancer test. The AIM-listed company’s stock rose 0.25p to 4.55p after UCLH confirmed it will roll out the Risk of Ovarian Cancer Algorithm (ROCA). UCLH is offering the service through its Familial [...]

New research has identified a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors.  CDK4/6 inhibitors, combined with hormone therapy, are the standard treatment for this advanced type of breast cancer The research findings may help personalise therapies and design new combinations. [...]